Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid SignalsGulidanna Shayan, Robert L. Ferris, Sandra P. Gibson et al.|Clinical Cancer Research|2017Cited by 80